Symbols / CVRX $7.98 +5.00% CVRx, Inc.

Healthcare • Medical Devices • United States • NMS
CVRX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Fundamentals
Scroll to Statements
Market Cap 209.97M Enterprise Value 184.76M Income -53.31M Sales 56.65M Book/sh 1.50 Cash/sh 2.88
Dividend Yield — Payout 0.00% Employees 223 IPO — P/E — Forward P/E -4.27
PEG — P/S 3.71 P/B 5.34 P/C — EV/EBITDA -3.66 EV/Sales 3.26
Quick Ratio 6.49 Current Ratio 7.63 Debt/Eq 128.43 LT Debt/Eq — EPS (ttm) -2.04 EPS next Y -1.87
EPS Growth — Revenue Growth 4.40% Earnings 2026-05-14 ROA -26.90% ROE -96.59% ROIC —
Gross Margin 85.33% Oper. Margin -69.80% Profit Margin -94.10% Shs Outstand 26.31M Shs Float 18.17M Short Float 8.69%
Short Ratio 7.39 Short Interest — 52W High 11.30 52W Low 4.30 Beta 1.12 Avg Volume 347.15K
Volume 257.07K Target Price $11.17 Recom Buy Prev Close $7.60 Price $7.98 Change 5.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.17
Mean price target
2. Current target
$7.98
Latest analyst target
3. DCF / Fair value
$-16.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.98
Low
$6.00
High
$14.00
Mean
$11.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 main Canaccord Genuity Buy → Buy $10
2026-02-13 main Canaccord Genuity Buy → Buy $10
2025-11-06 main Canaccord Genuity Buy → Buy $11
2025-11-06 main Cantor Fitzgerald Overweight → Overweight $13
2025-08-05 reit Cantor Fitzgerald Overweight → Overweight $11
2025-05-09 main Piper Sandler Overweight → Overweight $12
2025-05-09 down JP Morgan Neutral → Underweight $7
2025-04-08 main Lake Street Buy → Buy $14
2025-04-08 main Canaccord Genuity Buy → Buy $18
2025-02-05 main Piper Sandler Overweight → Overweight $20
2025-02-05 main Canaccord Genuity Buy → Buy $23
2025-01-17 main Craig-Hallum Buy → Buy $22
2025-01-14 up William Blair Market Perform → Outperform —
2024-12-09 main Canaccord Genuity Buy → Buy $22
2024-11-04 main Craig-Hallum Buy → Buy $20
2024-10-30 main Lake Street Buy → Buy $15
2024-10-30 main Canaccord Genuity Buy → Buy $17
2024-10-30 reit Piper Sandler Overweight → Overweight $16
2024-10-23 reit Cantor Fitzgerald Overweight → Overweight $14
2024-09-10 init Cantor Fitzgerald — → Overweight $14
News
RSS: Latest CVRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 MORRISON GREGORY Officer — 34,000 $0.00 $0
2026-03-02 HYKES KEVIN Chief Executive Officer — 7,763 $7.90 $61,349
2026-03-02 VERRASTRO PAUL Officer — 1,284 $7.90 $10,146
2026-03-02 OASHEIM JARED Chief Financial Officer — 1,744 $7.90 $13,781
2026-03-02 JOHN ROBERT ALLEN Officer — 3,964 $7.90 $31,326
2026-03-02 ADAMSON PHILIP B. Officer — 1,262 $7.90 $9,973
2026-02-27 HYKES KEVIN Chief Executive Officer — 159,000 $0.00 $0
2026-02-27 BINKOWSKI BRENT Chief Operating Officer — 15,000 $0.00 $0
2026-02-27 VERRASTRO PAUL Officer — 45,000 $0.00 $0
2026-02-27 OASHEIM JARED Chief Financial Officer — 61,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
56.65
+10.45%
51.29
+30.53%
39.30
+74.89%
22.47
Operating Revenue
56.65
+10.45%
51.29
+30.53%
39.30
+74.89%
22.47
Cost Of Revenue
8.31
-0.28%
8.33
+33.22%
6.26
+25.15%
5.00
Reconciled Cost Of Revenue
8.31
-0.28%
8.33
+33.22%
6.26
+25.15%
5.00
Gross Profit
48.34
+12.53%
42.96
+30.02%
33.04
+89.12%
17.47
Operating Expense
99.61
-2.78%
102.45
+34.55%
76.14
+26.91%
60.00
Research And Development
11.13
+0.01%
11.13
-4.32%
11.63
+16.89%
9.95
Selling General And Administration
88.47
-3.11%
91.32
+41.56%
64.51
+28.90%
50.05
Total Expenses
107.92
-2.59%
110.78
+34.45%
82.40
+26.77%
65.00
Operating Income
-51.27
+13.83%
-59.49
-38.02%
-43.10
-1.35%
-42.53
Total Operating Income As Reported
-51.27
+13.83%
-59.49
-38.02%
-43.10
-1.35%
-42.53
EBITDA
-46.74
+14.85%
-54.89
-41.73%
-38.73
+4.94%
-40.74
Normalized EBITDA
-46.74
+14.85%
-54.89
-41.73%
-38.73
+4.94%
-40.74
Reconciled Depreciation
0.76
+22.13%
0.62
+18.58%
0.52
+26.70%
0.41
EBIT
-47.50
+14.44%
-55.51
-41.42%
-39.25
+4.62%
-41.15
Net Income
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Pretax Income
-53.32
+10.99%
-59.91
-45.94%
-41.05
+0.65%
-41.32
Net Non Operating Interest Income Expense
-5.83
-32.52%
-4.40
-144.41%
-1.80
-990.30%
-0.17
Interest Expense Non Operating
5.83
+32.52%
4.40
+144.41%
1.80
+990.30%
0.17
Net Interest Income
-5.83
-32.52%
-4.40
-144.41%
-1.80
-990.30%
-0.17
Interest Expense
5.83
+32.52%
4.40
+144.41%
1.80
+990.30%
0.17
Other Income Expense
3.77
-5.26%
3.98
+3.30%
3.85
+180.41%
1.37
Other Non Operating Income Expenses
3.77
-5.26%
3.98
+3.30%
3.85
+180.41%
1.37
Tax Provision
-0.02
-132.73%
0.06
-62.59%
0.15
+34.86%
0.11
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Net Income From Continuing Operation Net Minority Interest
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Net Income From Continuing And Discontinued Operation
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Net Income Continuous Operations
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Normalized Income
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Net Income Common Stockholders
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Diluted EPS
-2.04
+23.02%
-2.65
-33.17%
-1.99
+1.49%
-2.02
Basic EPS
-2.04
+23.02%
-2.65
-33.17%
-1.99
+1.49%
-2.02
Basic Average Shares
26.08
+15.44%
22.60
+8.87%
20.75
+1.08%
20.53
Diluted Average Shares
26.08
+15.44%
22.60
+8.87%
20.75
+1.08%
20.53
Diluted NI Availto Com Stockholders
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Line Item Trend 2023-12-31
Total Assets
115.23
Current Assets
112.09
Cash Cash Equivalents And Short Term Investments
90.57
Cash And Cash Equivalents
90.57
Receivables
7.55
Accounts Receivable
7.55
Gross Accounts Receivable
8.06
Allowance For Doubtful Accounts Receivable
-0.51
Inventory
10.98
Raw Materials
4.71
Work In Process
0.65
Finished Goods
5.62
Prepaid Assets
—
Other Current Assets
2.99
Total Non Current Assets
3.14
Net PPE
3.11
Gross PPE
5.90
Accumulated Depreciation
-2.79
Properties
0.00
Machinery Furniture Equipment
1.18
Construction In Progress
0.55
Other Properties
4.07
Leases
0.10
Other Non Current Assets
0.03
Total Liabilities Net Minority Interest
39.28
Current Liabilities
7.86
Payables And Accrued Expenses
3.53
Payables
2.01
Accounts Payable
1.88
Current Accrued Expenses
1.52
Pensionand Other Post Retirement Benefit Plans Current
4.11
Total Tax Payable
0.12
Current Debt And Capital Lease Obligation
0.23
Current Capital Lease Obligation
0.23
Total Non Current Liabilities Net Minority Interest
31.42
Long Term Debt And Capital Lease Obligation
30.38
Long Term Debt
29.22
Long Term Capital Lease Obligation
1.16
Other Non Current Liabilities
1.04
Preferred Securities Outside Stock Equity
—
Stockholders Equity
75.95
Common Stock Equity
75.95
Capital Stock
0.21
Common Stock
0.21
Share Issued
20.88
Ordinary Shares Number
20.88
Treasury Shares Number
0.00
Additional Paid In Capital
553.33
Retained Earnings
-477.38
Gains Losses Not Affecting Retained Earnings
-0.21
Other Equity Adjustments
-0.21
Total Equity Gross Minority Interest
75.95
Total Capitalization
105.17
Working Capital
104.23
Invested Capital
105.17
Total Debt
30.61
Capital Lease Obligations
1.39
Net Tangible Assets
75.95
Tangible Book Value
75.95
Interest Payable
0.22
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-40.17
-2.62%
-39.14
-0.32%
-39.02
+8.57%
-42.68
Cash Flow From Continuing Operating Activities
-40.17
-2.62%
-39.14
-0.32%
-39.02
+8.57%
-42.68
Net Income From Continuing Operations
-53.31
+11.10%
-59.97
-45.55%
-41.20
+0.55%
-41.43
Depreciation Amortization Depletion
0.76
+22.13%
0.62
+18.58%
0.52
+26.70%
0.41
Depreciation
0.76
+22.13%
0.62
+18.58%
0.52
+26.70%
0.41
Depreciation And Amortization
0.76
+22.13%
0.62
+18.58%
0.52
+26.70%
0.41
Other Non Cash Items
0.24
+18.72%
0.20
+31.82%
0.15
+516.00%
0.03
Stock Based Compensation
11.05
-41.98%
19.05
+202.24%
6.30
+62.16%
3.89
Operating Gains Losses
0.09
—
0.00
—
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
0.09
0.00
-100.00%
0.00
0.00
Change In Working Capital
1.00
+5.48%
0.95
+119.75%
-4.80
+13.78%
-5.57
Change In Receivables
-1.40
+18.64%
-1.72
+16.12%
-2.05
+30.47%
-2.94
Changes In Account Receivables
-1.40
+18.64%
-1.72
+16.12%
-2.05
+30.47%
-2.94
Change In Inventory
-0.10
+91.28%
-1.12
+72.08%
-4.03
-30.84%
-3.08
Change In Prepaid Assets
-0.54
-202.26%
0.53
-58.29%
1.27
+177.91%
-1.63
Change In Payables And Accrued Expense
3.04
-6.75%
3.26
+65280.00%
-0.01
-100.24%
2.08
Change In Accrued Expense
1.79
-30.18%
2.56
+1606.47%
-0.17
-119.47%
0.87
Change In Payable
1.25
+79.23%
0.70
+323.03%
0.17
-86.35%
1.21
Change In Account Payable
1.25
+79.23%
0.70
+323.03%
0.17
-86.35%
1.21
Investing Cash Flow
-0.58
+57.38%
-1.36
-130.29%
-0.59
+13.72%
-0.69
Cash Flow From Continuing Investing Activities
-0.58
+57.38%
-1.36
-130.29%
-0.59
+13.72%
-0.69
Net PPE Purchase And Sale
-0.58
+57.38%
-1.36
-130.29%
-0.59
+13.72%
-0.69
Purchase Of PPE
-0.58
+57.38%
-1.36
-130.29%
-0.59
+13.72%
-0.69
Capital Expenditure
-0.58
+57.38%
-1.36
-130.29%
-0.59
+13.72%
-0.69
Financing Cash Flow
10.52
-81.17%
55.87
+132.95%
23.98
+220.09%
7.49
Cash Flow From Continuing Financing Activities
10.52
-81.17%
55.87
+132.95%
23.98
+220.09%
7.49
Net Issuance Payments Of Debt
0.00
-100.00%
20.00
-11.11%
22.50
+200.00%
7.50
Issuance Of Debt
0.00
-100.00%
20.00
-11.11%
22.50
+200.00%
7.50
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
0.00
-100.00%
20.00
-11.11%
22.50
+200.00%
7.50
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
0.00
-100.00%
20.00
-11.11%
22.50
+200.00%
7.50
Net Common Stock Issuance
8.97
-72.41%
32.52
0.00
0.00
Common Stock Payments
—
—
—
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
1.55
-55.84%
3.50
+110.52%
1.66
+115.69%
0.77
Net Other Financing Charges
—
-0.15
+15.08%
-0.18
+76.99%
-0.78
Changes In Cash
-30.23
-296.75%
15.37
+198.32%
-15.63
+56.43%
-35.87
Effect Of Exchange Rate Changes
0.01
+600.00%
-0.00
-133.33%
0.00
+133.33%
-0.01
Beginning Cash Position
105.93
+16.96%
90.57
-14.71%
106.19
-25.25%
142.07
End Cash Position
75.71
-28.53%
105.93
+16.96%
90.57
-14.71%
106.19
Free Cash Flow
-40.75
-0.60%
-40.51
-2.25%
-39.61
+8.65%
-43.36
Interest Paid Supplemental Data
5.04
+39.60%
3.61
+158.88%
1.40
+2266.10%
0.06
Income Tax Paid Supplemental Data
—
0.00
-100.00%
0.00
-20.00%
0.01
Common Stock Issuance
8.97
-72.41%
32.52
0.00
0.00
Issuance Of Capital Stock
8.97
-72.41%
32.52
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category